Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Irina A. Favorskaya"'
Autor:
Ilias B. Esmagambetov, Ekaterina I. Ryabova, Artem A. Derkaev, Dmitry V. Shcheblyakov, Inna V. Dolzhikova, Irina A. Favorskaya, Daria M. Grousova, Mikhail A. Dovgiy, Vladimir V. Prokofiev, Andrey I. Gosudarev, Daria V. Byrikhina, Ilia D. Zorkov, Anna A. Iliukhina, Anna V. Kovyrshina, Artem Y. Shelkov, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionNumerous agents for prophylaxis of SARS-CoV-2-induced diseases are currently registered for the clinical use. Formation of the immunity happens within several weeks following vaccine administration which is their key disadvantage. In cont
Externí odkaz:
https://doaj.org/article/435734489115452892c1fe539af6307b
Autor:
Irina A. Favorskaya, Dmitry V. Shcheblyakov, Ilias B. Esmagambetov, Inna V. Dolzhikova, Irina A. Alekseeva, Anastasia I. Korobkova, Daria V. Voronina, Ekaterina I. Ryabova, Artem A. Derkaev, Anna V. Kovyrshina, Anna A. Iliukhina, Andrey G. Botikov, Olga L. Voronina, Daria A. Egorova, Olga V. Zubkova, Natalia N. Ryzhova, Ekaterina I. Aksenova, Marina S. Kunda, Denis Y. Logunov, Boris S. Naroditsky, Alexandr L. Gintsburg
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Virus-neutralizing antibodies are one of the few treatment options for COVID-19. The evolution of SARS-CoV-2 virus has led to the emergence of virus variants with reduced sensitivity to some antibody-based therapies. The development of potent antibod
Externí odkaz:
https://doaj.org/article/f07abc82d4394ceda24adf1504e604ad
Autor:
Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
The Lancet Regional Health. Europe, Vol 11, Iss , Pp 100241- (2021)
Background: While the world is experiencing another wave of COVID-19 pandemic, global vaccination program is hampered by an evident shortage in the supply of licensed vaccines. In an effort to satisfy vaccine demands we developed a new single-dose va
Externí odkaz:
https://doaj.org/article/54fc97d8b69745aa9da8b8b6bf909e3d
Autor:
Daria V. Voronina, Dmitry V. Shcheblyakov, Irina A. Favorskaya, Ilias B. Esmagambetov, Alina S. Dzharullaeva, Amir I. Tukhvatulin, Olga V. Zubkova, Olga Popova, Vladislav Y. Kan, Alina S. Bandelyuk, Maxim M. Shmarov, Denis Y. Logunov, Boris S. Naroditskiy, Aleksandr L. Gintsburg
Publikováno v:
Viruses, Vol 14, Iss 11, p 2485 (2022)
The continued evolution of influenza viruses reduces the effectiveness of vaccination and antiviral drugs. The identification of novel and universal agents for influenza prophylaxis and treatment is an urgent need. We have previously described two po
Externí odkaz:
https://doaj.org/article/55d7dfa81f674cacac3748dcc5023fce
Autor:
Darya V. Voronina, Alina S. Bandelyuk, Alina Sh. Dzharullaeva, Olga Popova, Vladislav Yu. Kan, Ilias B. Esmagambetov, Irina A. Favorskaya, Dmitry V. Shcheblyakov, Boris S. Naroditskiy, Aleksandr L. Gintsburg
The continued evolution of influenza viruses reduces the effectiveness of vaccination and antiviral drugs. The identification of novel and universal agents for influenza prophylaxis and treatment is an urgent need. We have previously described two po
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35ca9b63aeeadf37f1ec40399c606adc
https://doi.org/10.1101/2022.09.29.510074
https://doi.org/10.1101/2022.09.29.510074
Autor:
Ekaterina I Ryabova, Dmitry V. Shcheblyakov, Denis Y. Logunov, Andrey G Botikov, Alexandr L. Gintsburg, Irina A Alekseeva, Ekaterina I. Aksenova, Irina A Favorskaya, Olga L. Voronina, Artem A Derkaev, Natalia N. Ryzhova, Boris S. Naroditsky, M.S. Kunda, Anna V. Kovyrshina, Ilias B Esmagambetov, Daria V Voronina, Daria A. Egorova, Inna V. Dolzhikova, Anna A. Iliukhina, Anastasia I Korobkova, Olga V. Zubkova
Virus-neutralizing antibodies are one of the few treatment options for COVID-19. The evolution of SARS-CoV-2 virus has led to the emergence of virus variants with reduced sensitivity to some antibody-based therapies. The development of potent antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::953137976c48f1113918d4e21bcf2bb8
https://doi.org/10.1101/2021.11.24.469842
https://doi.org/10.1101/2021.11.24.469842
Autor:
A. I. Tukhvatulin, Fatima M. Izhaeva, Denis Y. Logunov, Daria A. Egorova, Daria M. Grousova, Andrei G. Botikov, Alina S. Dzharullaeva, Sergei V. Borisevich, Olga Popova, Denis I. Zrelkin, Ilias B Esmagambetov, Alexander S. Semikhin, Daria V Voronina, Elena A Smolyarchuk, Dmitry N. Shcherbinin, Olga V. Zubkova, Nadezhda L. Lubenets, M M Shmarov, Anna V. Kovyrshina, Tatiana A Ozharovskaya, Boris S. Naroditsky, Dmitry V. Shcheblyakov, Inna V. Dolzhikova, Alexander L. Gintsburg, Irina A Favorskaya, Alina S. Erokhova, Natalia A. Nikitenko, Vladimir A. Gushchin, Sergey Zyryanov, Yana V. Simakova, Elizaveta A. Tokarskaya
Publikováno v:
The Lancet
Lancet (London, England)
Lancet (London, England)
Background A heterologous recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), showed a good safety profile and induced strong humoral and cellular immune responses in participants in phase 1/2 clinical trials. Here, we report preli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45be4c8958b8b211911b441dc840d66e
Autor:
Amir I. Tukhvatulin, Inna V. Dolzhikova, Dmitry V. Shcheblyakov, Olga V. Zubkova, Alina S. Dzharullaeva, Anna V. Kovyrshina, Nadezhda L. Lubenets, Daria M. Grousova, Alina S. Erokhova, Andrei G. Botikov, Fatima M. Izhaeva, Olga Popova, Tatiana A. Ozharovskaia, Ilias B. Esmagambetov, Irina A. Favorskaya, Denis I. Zrelkin, Daria V. Voronina, Dmitry N. Shcherbinin, Alexander S. Semikhin, Yana V. Simakova, Elizaveta A. Tokarskaya, Maksim M. Shmarov, Natalia A. Nikitenko, Vladimir A. Gushchin, Elena A. Smolyarchuk, Tatiana G. Zubkova, Konstantin A. Zakharov, Vasiliy B. Vasilyuk, Sergei V. Borisevich, Boris S. Naroditsky, Denis Y. Logunov, Alexander L. Gintsburg
Publikováno v:
SSRN Electronic Journal.
Background: While the world is experiencing another wave of COVID-19 pandemic, global vaccination program is hampered by obvious shortage in supply of licensed vaccines. Development of new vaccines that are easy to manufacture and administer is highl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46dd4f7e36c0425bc50de16bb4665594
https://doi.org/10.2139/ssrn.3886430
https://doi.org/10.2139/ssrn.3886430
Autor:
Tatiana A Ozharovskaya, Nadezhda L. Lubenets, Sergei V. Borisevich, Alexander S. Semikhin, Daria M. Grousova, Andrei G. Botikov, Yana V. Simakova, Fatima M. Izhaeva, Alina S. Erokhova, Denis I. Zrelkin, Olga V. Zubkova, Irina A Favorskaya, Elena A Smolyarchuk, Boris S. Naroditsky, M M Shmarov, Natalia A. Nikitenko, Alina S. Dzharullaeva, Alexander L. Gintsburg, Morozova Lf, Daria A. Egorova, Evgeny V Kryukov, Dmitry V. Shcheblyakov, Olga Popova, Denis Y. Logunov, Dmitry N. Shcherbinin, Inna V. Dolzhikova, Amir I Tukhvatullin, Elizaveta A. Tokarskaya, Ilias B Esmagambetov, Vladimir F Babira, Anna V. Kovyrshina, Daria V Voronina
Publikováno v:
Yana Simakova
Lancet (London, England)
The Lancet
Lancet (London, England)
The Lancet
Summary Background We developed a heterologous COVID-19 vaccine consisting of two components, a recombinant adenovirus type 26 (rAd26) vector and a recombinant adenovirus type 5 (rAd5) vector, both carrying the gene for severe acute respiratory syndr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b04ada67ad427528778d88936c6006e